Neuralink revenue and valuation
Specter estimates Neuralink's annual revenue at $115M to $330M and its valuation at $5.28B to $14.6B. The company was priced at $9.65B in May 2025.
- Estimated revenue
- $115M–$330M
- Estimated valuation
- $5.28B–$14.6B
- Total funding
- $1.34B
- Founded
- 2016
- Headquarters
- Austin, United States
- Employees
- 705
Neuralink revenue
Specter's model puts current revenue between $115M and $330M.
Monthly data
| Month | Specter estimate | Low | High | Reported revenue |
|---|---|---|---|---|
| $220M | $115M | $330M | ||
| $107M | $56M | $159M | ||
| $155M | $78M | $230M | ||
| $155M | $79M | $230M | ||
| $210M | $76M | $340M | ||
| $197M | $68M | $330M | ||
| $167M | $67M | $270M | ||
| $149M | $66M | $230M | ||
| $156M | $69M | $240M | ||
| $148M | $61M | $240M | ||
| $151M | $67M | $240M | ||
| $139M | $50M | $230M | ||
| $142M | $51M | $230M | ||
| $137M | $47M | $230M | ||
| $148M | $51M | $250M | ||
| $149M | $53M | $250M | ||
| $154M | $51M | $260M | ||
| $150M | $51M | $250M | ||
| $148M | $50M | $250M | ||
| $145M | $52M | $240M | ||
| $146M | $53M | $240M | ||
| $146M | $55M | $240M | ||
| $151M | $56M | $250M | ||
| $151M | $59M | $240M | ||
| $136M | $50M | $220M | ||
| $141M | $56M | $230M | ||
| $109M | $43M | $174M | ||
| $119M | $43M | $194M | ||
| $116M | $45M | $187M |
Neuralink valuation
Neuralink's valuation rose from $2B at its Series C in July 2021 to $9.65B at its Series E in May 2025. Specter's live estimate sits between $5.28B and $14.6B.
Monthly data
| Month | Specter estimate | Low | High | Reported valuation |
|---|---|---|---|---|
| $8.79B | $5.28B | $14.6B | ||
| $8.52B | $4.95B | $14.7B | ||
| $8.31B | $5.03B | $13.7B | ||
| $8.6B | $5.56B | $13.3B | ||
| $9.45B | $6.57B | $13.6B | ||
| $9.3B | $6.66B | $13B | ||
| $8.45B | $5.68B | $12.6B | ||
| $8.51B | $5.67B | $12.8B | ||
| $8.62B | $6.07B | $12.3B | ||
| $8.7B | $6.33B | $11.9B | ||
| $8.8B | $6.7B | $11.6B | ||
| $8.81B | $6.54B | $11.9B | ||
| $8.96B | $7.02B | $11.4B | ||
| $8.97B | $7.25B | $11.1B | ||
| $9B | $7.49B | $10.8B | $9B (press) | |
| $9B | $7.31B | $11.1B | ||
| $9B | $7.49B | $10.8B | $9B (press) | |
| $9.65B | $8.03B | $11.6B | $9.65B (round) | |
| $8.5B | $7.07B | $10.2B | $8.5B (press) | |
| $8.52B | $5.17B | $14.1B | ||
| $8.55B | $5.32B | $13.7B | ||
| $8.57B | $5.4B | $13.6B | ||
| $8.59B | $5.38B | $13.7B | ||
| $8.62B | $5.79B | $12.8B | ||
| $8.64B | $5.49B | $13.6B | ||
| $8.66B | $5.54B | $13.6B | ||
| $8.69B | $4.76B | $15.9B | ||
| $8.71B | $5.98B | $12.7B | ||
| $8.73B | $5.73B | $13.3B |
Neuralink funding rounds
| Date | Round | Raised | Post-money valuation | Lead investors |
|---|---|---|---|---|
| Venture round | Undisclosed | Undisclosed | Oman Investment Authority | |
| Venture round | Undisclosed | Undisclosed | CoreNest Capital | |
| Secondary | Undisclosed | Undisclosed | Undisclosed | |
| Series E | $649M | $9.65B | Undisclosed | |
| Secondary | Undisclosed | Undisclosed | Undisclosed | |
| Series D | $323M | Undisclosed | Founders Fund | |
| Secondary | Undisclosed | $5B | Undisclosed | |
| Secondary | Undisclosed | Undisclosed | Undisclosed | |
| Series C | $205M | $2B | Vy Capital | |
| Series B | $51M | Undisclosed | Undisclosed | |
| Series A | $107M | Undisclosed | Undisclosed |
Neuralink competitors
The brain-computer interface market splits between high-bandwidth invasive implants and safety-focused minimally invasive devices.
| Company | Revenue | Valuation |
|---|---|---|
| $115M–$330M | $5.28B–$14.6B | |
| $7.4M–$50M | $750M–$1.6B | |
| $9.8M–$30M | $35M–$210M | |
| $3.6M–$42M | $880M–$1.28B | |
| $15M–$87M | $1.22B–$1.78B |
Neuralink revenue and valuation FAQ
What is Neuralink's revenue?
Specter estimates Neuralink's annual revenue at $115M to $330M as of October 2026.
What is Neuralink's valuation?
Neuralink's latest post-money valuation is $9.65B, from a May 2025 Series E. Specter's live estimate is $5.28B to $14.6B.
How much funding has Neuralink raised?
$1.34B across 11 rounds, from a $107M Series A in August 2017 to a venture round in May 2026.
Who invested in Neuralink?
47 investors, including CoreNest Capital, Founders Fund, Oman Investment Authority and Vy Capital.
Who are Neuralink's competitors?
Synchron, Blackrock Neurotech, Precision Neuroscience and Science. Specter ranks 30 competitors for Neuralink.